What was recalled
This page synthesizes the manufacturing framework around post-extrusion enzyme glaze application in commercial kibble production. Kibble extrusion is the dominant manufacturing process for dry pet food, accounting for ~80% of commercial dog and cat food production globally. The process involves: (i) raw ingredient grinding and pre-conditioning with steam and water to reach ~25-30% moisture and 80-100°C; (ii) extrusion through a barrel screw under high pressure and shear, reaching peak temperatures of 100-130°C and ~30-50 bar pressure; (iii) die-plate forcing into kibble shapes with flash-cooling and rapid expansion as the kibble exits the die; (iv) drying tunnel processing to reduce moisture to ~8-10% for shelf stability; (v) optional post-extrusion glaze application with fats, palatants, vitamins, probiotics, and/or enzymes; (vi) cooling and packaging. The processing produces a shelf-stable kibble with ~12-month shelf life under typical commercial storage conditions.
The enzyme stability challenge in kibble manufacturing is fundamental. Enzymes are proteins, and proteins denature (lose three-dimensional structure necessary for enzymatic function) at elevated temperatures. Specific enzyme thermal inactivation temperatures vary: (i) protease enzymes — papain (from papaya, ~80°C), bromelain (from pineapple, ~70°C), alpha-chymotrypsin (~50°C), trypsin (~50°C), microbial proteases (varies, some thermostable Aspergillus and Bacillus proteases retain activity at 60-80°C); (ii) lipase enzymes — pancreatic lipase (~45°C), microbial lipases (varies, Candida antarctica lipase B retains activity at 60-70°C); (iii) amylase enzymes — alpha-amylase (varies widely; pancreatic ~45°C, but Thermomyces lanuginosus and Bacillus licheniformis variants retain activity at 80-110°C); (iv) cellulase enzymes — varies by source, most denature below 70°C. The 80-130°C peak extrusion temperature inactivates most enzymes, with exceptions for specifically-selected thermostable variants.
The post-extrusion glaze application framework resolves the thermal inactivation problem: kibble after drying-tunnel processing typically reaches surface temperatures of 40-60°C, well below the inactivation temperature for most enzymes. Spray-on application at this stage preserves enzyme viability through final packaging. The application typically uses a liquid carrier (fat or palatant solution) that adheres to the kibble surface and delivers the enzyme alongside other heat-sensitive ingredients (probiotics, water-soluble vitamins, palatants). The framework is similar for probiotic application, and many products co-apply enzymes with probiotics in a single post-extrusion glaze step.
Why it was recalled
The structural concerns have three layers. Layer one — consumer-disclosure of pre-extrusion versus post-extrusion enzyme application is essentially absent: pet food labels listing enzymes on the ingredient panel do not specify whether the enzymes were added pre-extrusion (in which case viability is uncertain) or post-extrusion (in which case viability is preserved). The framework gap is invisible to consumers, who cannot determine from the label whether the enzyme-fortified kibble actually delivers viable enzymes to the pet. Brand customer service may or may not disclose the processing detail.
Layer two — thermostable enzyme variants exist but are not universally used: some enzyme manufacturers produce thermostable variants (Bacillus licheniformis amylase, Aspergillus protease, microbial lipase variants) that retain viability through extrusion processing. The thermostable variants typically cost 2-5x more than standard variants and may not be universally adopted across pet food manufacturers. The framework gap is that a pet food listing "alpha-amylase" on the ingredient panel could include a thermostable variant (viable through extrusion) or a standard variant (inactivated through extrusion) with the label disclosure not distinguishing.
Layer three — CFU equivalent for enzymes (activity units) is rarely disclosed: enzyme activity is measured in defined activity units (U) per gram of product, with standard assays for each enzyme class (BAA units for protease, FCC units for lipase, DU units for amylase). Therapeutic enzyme dosing requires specific activity unit delivery. Pet food enzyme-fortification claims typically do not disclose activity units per serving, leaving the framework difficult to evaluate. A product including "alpha-amylase" at 0.001% of diet at standard activity may deliver substantively different effects than a product including the same enzyme at 0.1% of diet at high-activity formulation.
Health risks for your pet
Enzyme safety profile in pet food is generally favorable. Common pet food enzymes (alpha-amylase, protease, lipase, cellulase) are on FDA GRAS and AAFCO defined-ingredient lists with extensive industrial heritage. Theoretical safety considerations: (i) allergic sensitization — some plant-derived enzymes (papain from papaya, bromelain from pineapple) can produce allergic sensitization in occupationally-exposed workers in industrial production; clinical relevance to pets consuming kibble-glaze applied enzymes is minimal; (ii) microbial enzyme source safety — enzymes derived from microbial production (Aspergillus, Bacillus, Saccharomyces) require ingredient-safety verification at the manufacturer-tier; standard production sources have GRAS clearance; (iii) enzyme inhibitor presence — some plant ingredients in pet food contain enzyme inhibitors (raw legumes contain trypsin inhibitors, raw potato contains amylase inhibitors); processing typically inactivates inhibitors but raw or minimally-processed formulations may retain inhibitor activity affecting added-enzyme function.
The health-outcome benefits of viable enzyme inclusion in pet food are well-documented in companion-animal nutrition literature for specific contexts: (i) exocrine pancreatic insufficiency (EPI) — canine and feline EPI requires therapeutic enzyme supplementation; pet-food-included enzymes typically do not deliver therapeutic dose and require veterinary-tier supplementation (Pancrezyme, Viokase, Epiklin); (ii) digestive support in geriatric pets — modest evidence supports added digestive enzymes for pets with reduced endogenous enzyme production; (iii) fiber digestibility enhancement — cellulase and hemicellulase addition can modestly improve dietary fiber digestibility in dogs with cellulose-rich diets; (iv) phytate degradation — phytase addition improves mineral bioavailability from plant ingredients (most common in livestock feed; less common in pet food). The clinical contexts requiring therapeutic enzyme dosing typically warrant veterinary-tier supplements rather than reliance on kibble-included enzymes.
What to do if you bought affected product
Pet owners can navigate the enzyme-fortification framework meaningfully through several practical approaches: (1) recognize that enzyme inclusion on kibble ingredient panel requires post-extrusion application to be viable — most enzymes are heat-sensitive and would be inactivated by the 80-130°C extrusion process; brands using thermostable variants or post-extrusion spray application preserve enzyme viability; brands using standard variants pre-extrusion may not deliver viable enzymes; (2) contact brand customer service to confirm processing approach — established brands using viable enzyme fortification will typically confirm post-extrusion spray application or thermostable variant sourcing; brands unable or unwilling to confirm the processing approach may not deliver the enzyme as claimed; (3) look for products that disclose enzyme activity units — activity unit disclosure (BAA, FCC, DU per gram of product) is a strong evidence-quality signal; products disclosing total enzyme amount without activity unit framework may be over-claiming; (4) for exocrine pancreatic insufficiency (EPI), use veterinary-tier enzyme supplements — canine and feline EPI requires therapeutic enzyme dosing far above what pet food fortification provides; veterinary products (Pancrezyme, Viokase, Epiklin) deliver therapeutic dose in coordination with veterinary management; (5) for general digestive support, treat kibble-included enzymes as baseline support, not therapeutic intervention — if your pet has specific digestive concerns, consult with your veterinarian for targeted intervention rather than relying on kibble-included enzymes alone; (6) recognize that fresh, gently-cooked, and raw pet foods may include enzymes more reliably than kibble — the processing temperature constraint is specific to extrusion; cold-pressed, gently cooked, freeze-dried, and raw formulations preserve enzyme viability through different processing pathways; (7) understand probiotic and enzyme application share post-extrusion processing requirements — the same processing constraint applies to both categories; many products co-apply enzymes and probiotics in a single post-extrusion glaze step; (8) treat enzyme fortification as one transparency signal among several — brands disclosing processing approach, activity units, and source organism (Aspergillus, Bacillus, plant-source) typically demonstrate broader transparency across other ingredient categories.
How this affects KibbleIQ’s grade
The KibbleIQ rubric v15 does not currently differentiate viable versus inactivated enzyme inclusion in scoring per our published methodology, since the processing framework is rarely disclosed at consumer-facing label tier. Future rubric extension under consideration: brands publishing post-extrusion spray application detail, thermostable variant sourcing, and enzyme activity unit per serving would receive favorable scoring weight as evidence-quality and transparency signal. Related framework coverage is across our bromelain enzyme controversy, dental chew VOHC claim controversy, and downstream pages in this Tranche (pancreatic enzyme supplementation, digestive enzyme premix, dental chew enzyme mechanism). For now, our recommendation: recognize that enzyme-fortified kibble claims require post-extrusion processing to be viable, contact brand customer service to confirm processing approach for products claiming enzyme fortification, and use veterinary-tier enzyme supplements for specific clinical contexts requiring therapeutic dose.